Page 391 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 391
Bayer HealthCare 250 M
100 Bayer Boulevard, P.O. Box 915
Whippany, 07981
The United States
www.healthcare.bayer.com
The Bayer Group is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual
sales of EUR 20,0 billion (2014), is one of the world’s leading, innovative companies in
the healthcare and medical products industry and is based in Leverkusen, Germany. The
company combines the global activities of the Animal Health, Consumer Care, Medical
Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop,
manufacture and market products that will improve human and animal health worldwide.
Bayer HealthCare has a global workforce of 60,700 employees (Dec 31, 2014) and is
represented in more than 100 countries. More information is available at www.healthcare.
bayer.com.
BIOPREDICTIVE FIBROTEST 340 J
218, Boulevard Saint Gremain
Paris, 75007
France
www.biopredictive.com
BioPredictive offers diagnostic and prognostic blood tests for liver diseases. BioPredictive
is dedicated to improve the management of liver diseases. Over a million tests performed
worldwide. BioPredictive’s diagnosis and prognosis tests (FiboTest-ActiTest, FibroMax,
HCV-GenoFibroTest which combines IL28b and surrogate markers to anticipate Interferon
response and ElastoFibroTest, just rereleased, also available as an mobile app, combines
surrogate markers and transient elastography ) are available on line via a secured and
anonymous Internet connection www.biopredictive.com
Biotest AG 250 A INDUSTRY INFORMATION
5, Landsteinerstr
Dreieich, 63303
Germany
www.biotest.com
Biotest is a provider of plasma proteins and biological drugs. With a value added chain
that extends from pre-clinical and clinical development to worldwide sales, Biotest has
specialised primarily in the areas of clinical immunology, haematology and intensive
medicine. Biotest develops and markets immunoglobulins, coagulation factors and
albumins based on human blood plasma. These are used for diseases of the immune
and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the
indications of rheumatoid arthritis and cancer of plasma cells, which are produced by
recombinant technologies. Biotest has more than 2.100 employees worldwide.
Vienna, Austria • April 22–26, 2015 391
100 Bayer Boulevard, P.O. Box 915
Whippany, 07981
The United States
www.healthcare.bayer.com
The Bayer Group is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual
sales of EUR 20,0 billion (2014), is one of the world’s leading, innovative companies in
the healthcare and medical products industry and is based in Leverkusen, Germany. The
company combines the global activities of the Animal Health, Consumer Care, Medical
Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop,
manufacture and market products that will improve human and animal health worldwide.
Bayer HealthCare has a global workforce of 60,700 employees (Dec 31, 2014) and is
represented in more than 100 countries. More information is available at www.healthcare.
bayer.com.
BIOPREDICTIVE FIBROTEST 340 J
218, Boulevard Saint Gremain
Paris, 75007
France
www.biopredictive.com
BioPredictive offers diagnostic and prognostic blood tests for liver diseases. BioPredictive
is dedicated to improve the management of liver diseases. Over a million tests performed
worldwide. BioPredictive’s diagnosis and prognosis tests (FiboTest-ActiTest, FibroMax,
HCV-GenoFibroTest which combines IL28b and surrogate markers to anticipate Interferon
response and ElastoFibroTest, just rereleased, also available as an mobile app, combines
surrogate markers and transient elastography ) are available on line via a secured and
anonymous Internet connection www.biopredictive.com
Biotest AG 250 A INDUSTRY INFORMATION
5, Landsteinerstr
Dreieich, 63303
Germany
www.biotest.com
Biotest is a provider of plasma proteins and biological drugs. With a value added chain
that extends from pre-clinical and clinical development to worldwide sales, Biotest has
specialised primarily in the areas of clinical immunology, haematology and intensive
medicine. Biotest develops and markets immunoglobulins, coagulation factors and
albumins based on human blood plasma. These are used for diseases of the immune
and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the
indications of rheumatoid arthritis and cancer of plasma cells, which are produced by
recombinant technologies. Biotest has more than 2.100 employees worldwide.
Vienna, Austria • April 22–26, 2015 391
